High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia, a Phase 2 Trial.

被引：0
|
作者：
Powell, Bayard [1 ]
D'Agostino, Ralph, Jr. [1 ]
Levitan, Denise [1 ]
Ellis, Leslie Renee [1 ]
Lyerly, Susan [1 ]
Skiles, Megan [1 ]
Manuel, Megan [1 ]
Harrelson, Robin [1 ]
Kimbrough, Claire [1 ]
Hurd, David Duane [1 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [1] Limited phase I trial of sequential high dose cytarabine and clofarabine (HiDAC→CLOF) in relapsed or refractory acute myeloid leukemia.
    Powell, Bayard L.
    Lovato, James
    Kimbrough, Claire
    Lyerly, Susan
    Galloway-Daniels, Sonya
    Motley, Cathy
    Harrelson, Robin
    Keung, Yi Kong
    Thakuri, Mohan C.
    Molnar, Istvan
    Levitan, Denise
    Hurd, David Duane
    [J]. BLOOD, 2006, 108 (11) : 221B - 221B
  • [2] COMBINATION OF CLOFARABINE AND CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA
    Spassov, B.
    Balatzenko, G.
    Angelova, S.
    Toshkov, S.
    Guenova, M.
    Arnaudov, G.
    Mihaylov, G.
    [J]. HAEMATOLOGICA, 2015, 100 : 377 - 377
  • [3] Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study
    van Eijkelenburg, Natasha K. A.
    Rasche, Mareike
    Ghazaly, Essam
    Dworzak, Michael N.
    Klingebiel, Thomas
    Rossig, Claudia
    Leverger, Guy
    Stary, Jan
    De Bont, Eveline S. J. M.
    Chitu, Dana A.
    Bertrand, Yves
    Brethon, Benoit
    Strahm, Brigitte
    van der Sluis, Inge M.
    Kaspers, Gertjan J. L.
    Reinhardt, Dirk
    Zwaan, C. Michel
    [J]. HAEMATOLOGICA, 2018, 103 (09) : 1484 - 1492
  • [4] Phase I Trial of Clofarabine and High Dose Cytarabine with G-CSF Priming (G-CLAC) for Relapsed or Refractory Acute Myeloid Leukemia
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Hendrie, Paul C.
    Pagel, John M.
    Stirewalt, Derek
    Shustov, Andrei
    Storer, Barry E.
    Appelbaum, Frederick R.
    [J]. BLOOD, 2008, 112 (11) : 1018 - 1018
  • [5] Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Zeidner, Joshua F.
    Vincent, Benjamin G.
    Ivanova, Anastasia
    Moore, Dominic
    McKinnon, Karen P.
    Wilkinson, Alec D.
    Mukhopadhyay, Rupkatha
    Mazziotta, Francesco
    Knaus, Hanna A.
    Foster, Matthew C.
    Coombs, Catherine C.
    Jamieson, Katarzyna
    Van Deventer, Hendrik
    Webster, Jonathan A.
    Prince, Gabrielle T.
    DeZern, Amy E.
    Smith, B. Douglas
    Levis, Mark J.
    Montgomery, Nathan D.
    Luznik, Leo
    Serody, Jonathan S.
    Gojo, Ivana
    [J]. BLOOD CANCER DISCOVERY, 2021, 2 (06): : 616 - 629
  • [6] Successful Salvage Treatment With Clofarabine and Cytarabine In Relapsed/Refractory Acute Myeloid Leukemia
    Malato, Alessandra
    Acquaviva, Francesco
    Santoro, Alessandra
    Felice, Rosaria
    Magrin, Silvana
    Turri, Diamante
    Scime, Rosanna
    Di Bella, Raimondo
    Salemi, Domenico
    Fabbiano, Francesco
    [J]. BLOOD, 2013, 122 (21)
  • [7] Clofarabine and Low-Dose Cytarabine Combination in Relapsed/Refractory Acute Myeloid Leukemia Patients with High Risk Features
    Vigil, Carlos
    Jahan, Nusrat
    Paun, Oana
    Weis, Jennifer
    Heckman, Kevin
    Silverman, Margarida
    Carter, Thomas
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S297 - S297
  • [8] G-CSF Priming, Clofarabine and High Dose Cytarabine (GCLAC) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Storer, Barry E.
    Appelbaum, Frederick R.
    [J]. BLOOD, 2009, 114 (22) : 816 - 816
  • [9] Relapsed and Refractory Acute Myeloid Leukemia (AML) Treated with AS1411 and Cytarabine: A Randomized Phase II Trial.
    Stuart, Robert Kenneth
    Acton, Gary
    [J]. BLOOD, 2008, 112 (11) : 676 - 676
  • [10] A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia
    Short, Nicholas J.
    Kantarjian, Hagop
    Ravandi, Farhad
    Huang, Xuelin
    Xiao, Lianchun
    Garcia-Manero, Guillermo
    Plunkett, William
    Gandhi, Varsha
    Sasaki, Koji
    Pemmaraju, Naveen
    Daver, Naval G.
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Estrov, Zeev
    Kadia, Tapan M.
    Wierda, William G.
    DiNardo, Courtney D.
    Brandt, Mark
    O'Brien, Susan M.
    Cortes, Jorge E.
    Jabbour, Elias
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 813 - 820
12345